Aayush Food And Herbs Ltd reaches all-time high, outperforms sector by 1.47%
Aayush Food And Herbs Ltd, a microcap company in the pharma industry, has been gaining attention in the stock market with its recent 52-week and all-time high stock price of Rs.97.41. Despite a 'Sell' rating from MarketsMojo, the company has outperformed the sector by 1.47% and has shown a consecutive 21-day gain streak. Its strong performance and growth potential make it a promising player in the competitive pharma industry.
Aayush Food And Herbs Ltd, a microcap company in the pharma industry, has been making headlines in the stock market recently. On February 12, 2024, the company's stock price reached a 52-week high of Rs.97.41, which is also an all-time high for the company. This has caught the attention of investors and analysts alike.
According to MarketsMOJO, a leading stock market analysis platform, the stock call for Aayush Food And Herbs is currently 'Sell'. However, the company's performance today has outperformed the sector by 1.47%. This is a significant achievement for a microcap company in the highly competitive pharma industry.
The stock has been on a consecutive gain streak for the last 21 days, with a remarkable 51.38% increase in its value during this period. Today, the stock opened with a gap up of 2% and touched an intraday high of Rs.97.41. It has been trading at this price since then, indicating a strong hold in the market.
Aayush Food And Herbs is also performing well in terms of moving averages, as it is currently trading higher than the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This is a positive sign for the company's future growth and stability.
In the past year, Aayush Food And Herbs has shown an impressive performance of 267.58%, while the Sensex has only grown by 17.43%. This further highlights the company's potential and success in the pharma industry.
Overall, Aayush Food And Herbs is a microcap company that has been making waves in the stock market with its consistent growth and strong performance. With its recent 52-week and all-time high, the company is definitely one to watch out for in the pharma industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
